Xylem (NYSE:XYL) Price Target Raised to $165.00

Xylem (NYSE:XYL) had its price target lifted by Robert W. Baird from $163.00 to $165.00 in a report published on Wednesday, MarketBeat.com reports. Robert W. Baird currently has an outperform rating on the industrial products company’s stock.

A number of other equities analysts also recently commented on XYL. UBS Group boosted their target price on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. CLSA upgraded shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Oppenheimer lowered their price target on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Royal Bank Of Canada increased their price objective on shares of Xylem from $157.00 to $159.00 and gave the company an “outperform” rating in a report on Thursday, July 16th. Finally, Barclays lifted their price target on Xylem from $154.00 to $159.00 and gave the stock an “overweight” rating in a report on Wednesday. Nine equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $154.00.

Xylem Trading Up 0.4%

XYL opened at $117.29 on Wednesday. Xylem has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $27.39 billion, a P/E ratio of 27.93, a PEG ratio of 1.62 and a beta of 1.03. The stock’s fifty day moving average is $115.23 and its two-hundred day moving average is $122.12.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.34 by $0.12. The firm had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Analysts forecast that Xylem will post 5.67 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were given a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s dividend payout ratio (DPR) is presently 42.79%.

Insider Buying and Selling

In other Xylem news, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. The trade was a 54.22% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.

Institutional Trading of Xylem

Large investors have recently bought and sold shares of the company. Commonwealth Retirement Investments LLC acquired a new position in Xylem in the fourth quarter worth $27,000. Wexford Capital LP acquired a new stake in shares of Xylem in the third quarter valued at $27,000. Global Assets Advisory LLC bought a new stake in Xylem during the first quarter worth approximately $40,000. FWL Investment Management LLC purchased a new position in Xylem in the 2nd quarter worth about $43,000. Finally, Entrust Financial LLC acquired a new stake in Xylem during the 4th quarter worth about $45,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.